Literature DB >> 27692643

Elimination of visceral leishmaniasis on the Indian subcontinent.

Om Prakash Singh1, Epco Hasker2, Marleen Boelaert2, Shyam Sundar3.   

Abstract

Visceral leishmaniasis is a serious public health problem on the Indian subcontinent, causing high morbidity and mortality. The governments in the region launched a visceral leishmaniasis elimination initiative in 2005. We review knowledge gaps and research priorities. Key challenges include low coverage of health services for those most at risk, drug resistance, the absence of a vaccine, and the complex biology of the sandfly-human host transmission cycle. Vector control is an essential component, but innovation in this field is insufficient. Substantial progress has been made in the area of diagnostic, therapeutic, and vaccine development, but there are still many hurdles to overcome. For visceral leishmaniasis elimination to become a reality, effective deployment of these existing and new tools is essential. A strong commitment at community level is imperative, and appropriate diagnostic and treatment services as well as effective epidemiological surveillance need to be ensured.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27692643      PMCID: PMC5177523          DOI: 10.1016/S1473-3099(16)30140-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  52 in total

1.  Management of visceral leishmaniasis in rural primary health care services in Bihar, India.

Authors:  E Hasker; S P Singh; P Malaviya; R P Singh; R Shankar; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2010-07       Impact factor: 2.622

2.  Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?

Authors:  M Addy; A Nandy
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

Review 3.  Changing trends in the epidemiology, clinical presentation, and diagnosis of Leishmania-HIV co-infection in India.

Authors:  Sarman Singh
Journal:  Int J Infect Dis       Date:  2014-10-22       Impact factor: 3.623

4.  Susceptibility of the sandfly Phlebotomus argentipes Annandale and Brunetti (Diptera: Psychodidae) to insecticides in endemic areas of visceral leishmaniasis in Bihar, India.

Authors:  Ram Singh; Pramod Kumar
Journal:  Jpn J Infect Dis       Date:  2014-11-25       Impact factor: 1.362

5.  Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.

Authors:  Suman Rijal; Bart Ostyn; Surendra Uranw; Keshav Rai; Narayan Raj Bhattarai; Thomas P C Dorlo; Jos H Beijnen; Manu Vanaerschot; Saskia Decuypere; Subodh S Dhakal; Murari Lal Das; Prahlad Karki; Rupa Singh; Marleen Boelaert; Jean-Claude Dujardin
Journal:  Clin Infect Dis       Date:  2013-02-20       Impact factor: 9.079

Review 6.  Whole blood assay and visceral leishmaniasis: Challenges and promises.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Immunobiology       Date:  2014-01-31       Impact factor: 3.144

Review 7.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.

Authors:  Emiliano Lucero; Simon M Collin; Sujit Gomes; Fatima Akter; Asaduzzam Asad; Asish Kumar Das; Koert Ritmeijer
Journal:  PLoS Negl Trop Dis       Date:  2015-04-02

9.  How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.

Authors:  Rajib Chowdhury; Dinesh Mondal; Vashkar Chowdhury; Shyla Faria; Jorge Alvar; Shah Golam Nabi; Marleen Boelaert; Aditya Prasad Dash
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

10.  The household costs of visceral leishmaniasis care in south-eastern Nepal.

Authors:  Surendra Uranw; Filip Meheus; Rob Baltussen; Suman Rijal; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more
  43 in total

Review 1.  Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis.

Authors:  Malcolm S Duthie; Aurore Lison; Orin Courtenay
Journal:  Trends Parasitol       Date:  2018-08-18

Review 2.  Molecular Diagnosis of Visceral Leishmaniasis.

Authors:  Shyam Sundar; Om Prakash Singh
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 3.  Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Authors:  Fabiana Alves; Graeme Bilbe; Séverine Blesson; Vishal Goyal; Séverine Monnerat; Charles Mowbray; Gina Muthoni Ouattara; Bernard Pécoul; Suman Rijal; Joelle Rode; Alexandra Solomos; Nathalie Strub-Wourgaft; Monique Wasunna; Susan Wells; Eduard E Zijlstra; Byron Arana; Jorge Alvar
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 4.  Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.

Authors:  Om Prakash Singh; Mallikarjuna Rao Gedda; Shyam Lal Mudavath; Onkar Nath Srivastava; Shyam Sundar
Journal:  Nanomedicine (Lond)       Date:  2019-07-17       Impact factor: 5.307

Review 5.  Chemotherapeutics of visceral leishmaniasis: present and future developments.

Authors:  Shyam Sundar; Anup Singh
Journal:  Parasitology       Date:  2017-12-07       Impact factor: 3.234

6.  Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak.

Authors:  Ádila L M Lima; Iraci D de Lima; José F V Coutinho; Úrsula P S T de Sousa; Marcos A G Rodrigues; Mary E Wilson; Richard D Pearson; José W Queiroz; Selma M B Jerônimo
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-10-01       Impact factor: 2.184

Review 7.  Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.

Authors:  Shyam Sundar; Om Prakash Singh; Jaya Chakravarty
Journal:  Expert Rev Anti Infect Ther       Date:  2018-10-10       Impact factor: 5.091

8.  Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.

Authors:  Nadira D Karunaweera; Marcelo U Ferreira
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

Review 9.  Nanodiagnostics in leishmaniasis: A new frontiers for early elimination.

Authors:  Mallikarjuna Rao Gedda; Prasoon Madhukar; Ashish Shukla; Shyam Lal Mudavath; Onkar Nath Srivastava; Om Prakash Singh; Shyam Sundar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-03

Review 10.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.